The global canine influenza vaccine market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period (2022-2028). Canine influenza is a highly contagious viral infection that affects both the cat and dog populations. Canine influenza is a Type A influenza virus that can be identified by two specific proteins found in the lipid outer layer of the capsid, hemagglutinin and neuraminidase. Increased collaboration and partnership, as well as technological advancements in vaccine delivery devices, all contribute to market growth. Furthermore, rising healthcare expenditure and rising R&D spending provide opportunities for market growth. However, product recalls, stringent regulations, and a scarcity of skilled professionals could stymie the global canine influenza vaccine market.
Browse the full report description of “Global Canine influenza vaccine Market Size, Share & Trends Analysis Report by Type (Powder and Dry), and by End-User (Home, Pet Clinic and Others) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/canine-influenza-vaccine-market
The rising number of cases of canine influenza is propelling the market forward. Rapid turnaround time and lower procedure costs when compared to traditional methods are also driving the growth of the canine influenza treatment market. Pet adoption and reimbursement procedures are also available in many countries, including the United States and Europe. The global market for canine influenza treatment, on the other hand, is expected to be hampered by a limited number of vaccines available on the market, as well as raising revenue in the canine influenza treatment market. For instance, in 2022, the World Health Organization (WHO) today announced recommendations for the viral composition of influenza vaccines for the northern hemisphere's 2022-2023 influenza season. The announcement was made at the conclusion of a four-day Information Meeting on the Composition of Influenza Virus Vaccines, which is held twice a year.
Market Coverage
• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By End-users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Bristol-Myers Squibb Co., Boehringer Ingelheim Int. GmbH, Eli Lilly & Co., GlaxoSmithKline Plc., Novartis AG, Pfizer Inc., Sanofi, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Zoetis Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Canine Influenza Vaccine Market Report Segment
By Type
By Material
Global Canine Influenza Vaccine Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/canine-influenza-vaccine-market